SCHEMBL2496408

SCHEMBL2496408

CC[C@H](NC1(c2ccccc2OC)C(=O)Nc2ccc(Cl)cc21)C(=O)N(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CBX7 O95931 2/20 0.40
CDYL Q9Y232 2/20 0.40
KMT2A Q03164 2/20 0.40
IDO1 P14902 2/20 0.39
ADCY8 P40145 1/20 0.38
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CDYL2 Q8N8U2 1/20 0.36
CDY1; CDY1B Q9Y6F8 1/20 0.36
SCN9A Q15858 1/20 0.36
MDM2 Q00987 1/20 0.35
KCNQ3 O43525 1/20 0.35
KCNQ2 O43526 1/20 0.35
KCNQ4 P56696 1/20 0.35
KCNMA1 Q12791 1/20 0.35
KCNQ5 Q9NR82 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492829 0.93 KMT2A (0.40) CBX7CDYLKMT2AIDO1ADCY8
SCHEMBL2498534 0.91 CBX7 (0.39) CBX7CDYLKMT2AIDO1ADCY8
SCHEMBL2501794 0.91 CBX7 (0.39) CBX7CDYLKMT2AIDO1ADCY8
SCHEMBL2492782 0.90 PYGL (0.44) CBX7CDYLKMT2A
SCHEMBL2498800 0.90 CBX7 (0.38) CBX7CDYLKMT2AIDO1ADCY8
SCHEMBL2499409 0.89 CBX7 (0.38) CBX7CDYLKMT2AIDO1ADCY8
SCHEMBL2496689 0.88 CBX7 (0.37) CBX7CDYLKMT2AIDO1LMNA
SCHEMBL2496860 0.88 CBX7 (0.37) CBX7CDYLKMT2AIDO1ADCY8
SCHEMBL2497477 0.87 KMT2A (0.42) CBX7CDYLKMT2AIDO1ADCY8
SCHEMBL2492996 0.87 KMT2A (0.42) CBX7CDYLKMT2AIDO1ADCY8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 CBX7 4226/4885CDYL 3793/4885KMT2A 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.